Kinami, T., Uchikawa, S., Kawaoka, T., Yamasaki, S., Kosaka, M., Johira, Y., . . . Oka, S. (2024). Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma. Wiley.
Chicago Style (17th ed.) CitationKinami, Takahiro, et al. Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients with Portal Hypertension for Unresectable Hepatocellular Carcinoma. Wiley, 2024.
MLA (9th ed.) CitationKinami, Takahiro, et al. Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients with Portal Hypertension for Unresectable Hepatocellular Carcinoma. Wiley, 2024.
Warning: These citations may not always be 100% accurate.